Abstract
Background: Although several studies examined the association between e-cigarettes, substance use, and mental health conditions, there is limited research on whether COVID-19-related stress and health outcomes, mental health symptoms, and substance use differ by the frequency of e-cigarette use during the COVID-19 pandemic. We assessed the association of past 30-day frequent use of e-cigarettes with alcohol, cannabis, anxiety/depression, and COVID-19 impact. Methods: We conducted a national online cross-sectional survey among a random sample of US adults aged 18 years or older (N = 5065) between 13 May 2021, and 9 January 2022. A multinomial logistic regression analysis was performed to assess the study aims. Results: Of the participants, 7.17% reported once to several times per month (OSTPM), 6.95% reported once to several times per week (OSTPW), and 6.57% reported every day to several times per day (ESTPD) use of e-cigarettes in the past month. Alcohol and cannabis use ESTPD and once to several times per week/month (OSTPW/M) were associated with a higher likelihood of e-cigarette use ESTPD and OSTPW/M, respectively. Anxiety/depression was associated with e-cigarette use ESTPD and OSTPW. Individuals who considered social distancing to be stressful were more likely to use e-cigarettes ESTPD and OSTPW/M compared to those that considered social distancing as not stressful. Conclusion: Individuals who engaged in the frequent use of alcohol or cannabis, had depression/anxiety, and considered social distancing to be stressful were more likely to engage in frequent e-cigarette use. Improving efforts geared toward reducing the use of substances may help decrease the health risks associated with e-cigarette use.
Funder
National Institute on Minority Health and Health Disparities
Subject
Behavioral Neuroscience,General Psychology,Genetics,Development,Ecology, Evolution, Behavior and Systematics
Reference71 articles.
1. Impact of the COVID-19 pandemic—A mental health service perspective;Prog. Neurol. Psychiatry,2021
2. Choi, E.P.H., Hui, B.P.H., and Wan, E.Y.F. (2020). Depression and Anxiety in Hong Kong during COVID-19. Int. J. Environ. Res. Public Health, 17.
3. How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer;Future Oncol.,2020
4. Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19: A Meta-analysis;JAMA Pediatr.,2021
5. Association, A.P. (2022, June 02). Psychologists Report Large Increase in Demand for Anxiety, Depression Treatment. Available online: https://www.apa.org/news/press/releases/2020/11/telehealth-survey-summary.pdf.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献